1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole
C36H36N6 — CID 122202423
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole
1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole (PubChem CID 122202423) has the molecular formula C36H36N6 and a molecular weight of 552.73 g/mol. Its IUPAC name is 1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole.
Molecular Properties
| Compound Name | 1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole |
|---|---|
| PubChem CID | 122202423 |
| Molecular Formula | C36H36N6 |
| Molecular Weight | 552.73 g/mol |
| Exact Mass | 552.30 |
| IUPAC Name | 1-[3,5-bis(5,6-dimethylbenzimidazol-1-yl)-2,4,6-trimethylphenyl]-5,6-dimethylbenzimidazole |
| SMILES | Cc1cc2ncn(-c3c(C)c(-n4cnc5cc(C)c(C)cc54)c(C)c(-n4cnc5cc(C)c(C)cc54)c3C)c2cc1C |
| InChI | InChI=1S/C36H36N6/c1-19-10-28-31(13-22(19)4)40(16-37-28)34-25(7)35(41-17-38-29-11-20(2)23(5)14-32(29)41)27(9)36(26(34)8)42-18-39-30-12-21(3)24(6)15-33(30)42/h10-18H,1-9H3 |
| InChIKey | AVYNYXZAVBSFAK-UHFFFAOYSA-N |
| XLogP | 8.48 |
| TPSA | 53.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 552.73 |
| LogP ≤ 5 | 8.48 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122202423 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.